Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

Maintenance of immunity to COVID after infection or vaccination
21 July 2022
New clinical symptoms identified in largest international case series of confirmed monkeypox cases
21 July 2022

Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses.

Comments are closed.